Table 2 Effects of AbMIP and placebo on endothelial function, blood pressure and triglyceride

0.603 ± 0.274 (0.49–0.716)

0.552 ± 0.274 (0.439–0.665)

−0.052 ± 0.271 (−0.163–0.06)

0.481 ± 0.373 (0.327–0.635)

0.551 ± 0.339 (0.411–0.691)

0.070 ± 0.327 (−0.065–0.205)

0.047

0.642

136.8 ± 7.9 (133.5–140.0)

133.2 ± 6.9 (130.4–136.1)

−3.5 ± 6.1 (−6.0–(−1.0)) ^a

137.4 ± 7.7 (134.2–140.6)

132.8 ± 9.1 (129.1–136.6)

−4.6 ± 6.6 (−7.3–(−1.8)) ^a

0.586

0.221

84.8 ± 4.2 (83.1–86.6)

83.5 ± 4.4 (81.7–85.3)

−1.4 ± 4.3 (−3.1–0.4)

83.2 ± 4.5 (81.4–85.1)

82.2 ± 5.9 (79.8–84.6)

−1.0 ± 3.3 (−2.4–0.3)

0.763

0.119

116.2 ± 53.0 (94.4–138.1)

116.3 ± 43.0 (98.5–134.0)

0.0 ± 38.3 (−15.8–15.8)

117.0 ± 46.5 (97.8–136.2)

103.0 ± 40.4 (86.3–119.6)

−14.0 ± 27.9 (−25.5–(−2.5)) ^a

0.108

0.533

Pre fat meal

post fat meal

∆ post-pre fat meal

Pre fat meal

post fat meal

^∆ post-pre fat meal

0.552 ± 0.274 (0.439–0.665)

0.754 ± 0.261 (0.646–0.862)

0.202 ± 0.234 (0.106–0.299)^∆

0.551 ± 0.339 (0.411–0.691)

0.873 ± 0.171 (0.802–0.943)

0.322 ± 0.384 (0.164–0.48)^∆

0.201

0.659